Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HBB | P68871 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | PNP | P00491 | 7/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | EDNRA | P25101 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | HPRT1 | P00492 | 4/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.39 |
| ▸ | POLG | P54098 | 1/20 | 0.38 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12629791 | 0.90 | MEN1 (0.46) | MEN1KMT2AHBBMAPK1PNP | |
| SCHEMBL630850 | 0.82 | PNP (0.67) | MEN1KMT2AHBBMAPK1PNP | |
| Valacyclovir SCHEMBL13604679 | 0.80 | MEN1 (0.68) | MEN1KMT2AHBBMAPK1PNP | |
| SCHEMBL15912304 | 0.80 | MEN1 (0.46) | MEN1KMT2AHBBMAPK1PNP | |
| Acyclovir SCHEMBL9828560 | 0.79 | PNP (0.61) | MEN1KMT2AHBBMAPK1PNP | |
| Trifluoroacetic Acid SCHEMBL631061 | 0.77 | PNP (0.59) | MEN1KMT2AHBBMAPK1PNP | |
| SCHEMBL13604678 | 0.75 | MEN1 (0.50) | MEN1KMT2AHBBMAPK1PNP | |
| SCHEMBL11249941 | 0.74 | MEN1 (0.57) | MEN1KMT2AHBBMAPK1PNP | |
| SCHEMBL9366819 | 0.73 | MEN1 (0.56) | MEN1KMT2AHBBMAPK1PNP | |
| SCHEMBL11249255 | 0.70 | EGFR (0.46) | MEN1KMT2AHBBMAPK1PNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2011513433-A | — | — | 2011-04-28 | — | — | JP | claimed |
| EP-2257294-A2 | TREATMENT OF HERPES VIRUS RELATED DISEASES | Exley, Ray W. (US) | 2010-12-08 | — | — | EP | claimed |
| WO-2009111739-A2 | TREATMENT OF HERPES VIRUS RELATED DISEASES | EXLEY RAY W (US) | 2009-09-11 | — | — | WO | claimed |
| US-20110112117-A1 | TREATMENT OF HERPES VIRUS RELATED DISEASES | EXLEY RAY W | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112117-A1 | TREATMENT OF HERPES VIRUS RELATED DISEASES | TPMT, METAP2, DNPEP | MEN1 1674/4885KMT2A 1208/4885HBB 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.